Angiotensin II Contributes to the Pathophysiology of Heart Failure

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2018, Vol 2, Issue 4

Abstract

Angiotensin is a protein hormone; it is a part of the renin-angiotensin system (RAS), that causes blood vessels to become narrower, helps to maintain blood pressure and fluid balance in the body. It is the primary effector hormone that secreted in response to physiological stimuli. Despite, there is now general agreement that RAS is known to be much more complicated, acting locally within organs or tissue, through both intracrine and autocrine/paracrine mechanisms and systemically, to exert its effects on target organs, including the heart. High secretion of angiotensin II is a common problem resulting in excess fluid retained by the body and, ultimately, raised blood pressure frequency occurs in heart failure where angiotensin is also thought to take part in growing the heart size. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are used in the clinic to avoid these adverse effects. Besides, High levels of Ang II often causes hypertension, renal failure, and cardiac fibrosis. In this review, will be illustrated how Chronic Activation of the renin-angiotensin System Induces heart failure and injures endothelial cells by activation of cellular suicide pathways leading to apoptosis. Its Effects mediated by angiotensin II receptor (AT2) are suggested to include inhibition of cell growth, fetal tissue progression, extracellular matrix modulation, neuronal regeneration, cellular differentiation, apoptosis, and may be vasodilation and left ventricular hypertrophy.

Authors and Affiliations

Zaher AME and Ali SMR*

Keywords

Related Articles

Carbohydrates Test and In Vitro Inhibitory Activities of AlphaGlucosidase and Alpha-Amylase of Stem Bark Extracts of Musanga Cecropioides

Elevated postprandial hyperglycemia is one of the risk factors linked to diabetes. Decreasing postprandial hyperglycemia is possible by inhibiting certain carbohydrate hydrolyzing enzymes like α-amylase and α-glucosidase...

G-Reactor at Micro-Plant

The stirrer reactor govern the industrial pharmaceutical productions up to the present, however the complex transmission systems may increase the costs exponentially with the power rates and the hermetic rector sealing....

Antidiabetic Activity of Pereskia Bleo Aqueous Extracts in Alloxan Induced Diabetic Rats

Pereskia bleo Kunth (Cactaceae) is locally known as ‘Jarum tujuh bilah’. It has been used traditionally by local Malays for the treatment of diabetes. This study investigates the antidiabetic activity of aqueous extract...

Irrational Use of the Treatment for H. Pylori Guidelines

The gastric ulcer is epidemic disease in many countries the main cause of the disease is helicobacter pylori which transfers by polluted foods. Many protocols and guidelines for the treatment and the most common guidelin...

C-termini Analysis of Monoclonal Antibody Fragmentation

Fragmentation of therapeutic monoclonal antibodies (mAbs) is a critical quality attribute (CQA) that needs to be monitored and controlled during the biopharmaceutical drug development. Fragmentation of a protein is a res...

Download PDF file
  • EP ID EP745928
  • DOI 10.23880/oajpr-16000169
  • Views 34
  • Downloads 0

How To Cite

Zaher AME and Ali SMR* (2018). Angiotensin II Contributes to the Pathophysiology of Heart Failure. Open Access Journal of Pharmaceutical Research, 2(4), -. https://europub.co.uk./articles/-A-745928